pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-190b |
Genomic Coordinates | chr1: 154193665 - 154193743 |
Description | Homo sapiens miR-190b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-190b |
Sequence | 11| UGAUAUGUUUGAUAUUGGGUU |31 |
Evidence | Not_experimental |
Experiments | |
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Mtmr6 | ||||||||||||||||||||
Synonyms | 4022440C11Rik, AI428804, AU041072 | ||||||||||||||||||||
Description | myotubularin related protein 6 | ||||||||||||||||||||
Transcript | NM_144843 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Mtmr6 | |||||||||||||||||||||
3'UTR of Mtmr6 (miRNA target sites are highlighted) |
>Mtmr6|NM_144843|3'UTR 1 CCTCCTTCCGTGATCCCTGGATGACTGTAGTGTAAGAAATGTATAGTTGTGAGGATGGTCTGTACACATGGGCAGGAGGG 81 GTTGTTGAGTGACTTTGGGGCTTAGCAGTAAGTGAGAAAGTAGGTAGCTGAGAAAAGGATCATAGCAACTCTTGAGAGGA 161 GTGAGTCAGCTAAGTGCCATTTGTAACAAGAACATACTCATTTCTGTAGGAAGTGAGTGCTAGTGTGTGTATGTACTGGA 241 AAGGGGTTACACAGGACTGGTGAGCTGACAGTCTGTTGATTCAGATGTTAATTCCAGCCACGCTCAGTAGCTTTCCTCTA 321 ACTCTGAGAAAACAGACCTGACAACCTGAACCCTCAGTGACTGATGTGGCATGTGCTTTCAGTTCTGGAGCTGTGTGACT 401 GTGGATTTTGCAGTCACAAAAATCCAAATATATAGTCAAAAATATAGTGACGTTTTAACATTAAAGTGCCATGAAAAGTA 481 CTTATGGGACAGCCTTAAAGTAGACTCTCAGTTTATTCTGTGGGTTTTATAGCCGAGGACAGGATGTTTGATCTCTCCTT 561 TAATCAGCCTTATTTCATATGAAGAACTAACTGCACTCTGATTACTTGGGGGCCGCACACTGCAGTGCTCCACCATGGAA 641 AGTTGTAGACATACTCTGCTAGTTTGTAATTAGCCAGCTCCACCCGTATTTAAAATCAGTGTTACCGAAGGCTTTGTTCT 721 CGTTGTCATTTGTTCCAAGCTGCAGCTGACAGTTCATTATTCACAGCTTAGAGGACTCATTTCTTAGGCTAGTATAAGCA 801 CATTTGGCATTTACTTTCGGCTTACTGCAGTCTATTAATTCTTACTCTGTGGTTGGCTTTAATCCTTTGATAACTGTACA 881 TTTAAAGTGGCAAAGCTCTAAAGCGTTCTGAGTACTAAATACATTTTTAACTTGACTGTAGCTGCCTATAAACTTTCAGG 961 TAAAGGAAAAAGGGAAGTGCGGGTAGTGGAGATTTTGCTTGGTTACGAATTCTAAAGCAATCATTTTTGTGTGGAGCATA 1041 TTTCCTTACTCTTAATATAGGAGGGGCAGAGAAGGGAGCACTGGGGGAGCCAGCTAATGTCCAACAGAAGCAGCTTTGAC 1121 GCAGGAAAAGGTTTATTTTGCTTTATAGGCTCATTGTTATTCTGTGCACTGGGGCATACATATCTTTTCTAAAAAATCAC 1201 TTACAACTGTCAGTATTACCAGCTGGCTCTCAAAGTTTAATATCATTGATGGTGTGTGAGGTACAGTTCAGGGGCACTAC 1281 AAAATCTGTGTACATTGTCTTATATACCTCCTGACCACACCTATATCTGTAGTATTTCTTGTGTTAGTTTTGAACATATG 1361 TATCTTTTTTTTTTTTTTGGGAAAAAAAAGGAAAGCTTTATCGTATATGATTTTATCTAGTCCTTATTTTTCCAATTCAC 1441 TTCTGTAAGACCTTATGTAATAAAAACACTGCATTTTAAAAAGTAACAGAAATATACTAAAAATTACAATGTATAATGAA 1521 CAGTGTTTAGACATTGAGAAAGGAAACTTAATCTCTGTGTCCACAACAGGAGGGTTTTGTGCCTTGGTTCCAGTCAAGTT 1601 GTGGTTTTAGACTTCTGTGGCAGACTTCCTAGTCATCTTCTGGGTTCCTTATGCTAATTTTCAACTTCACATGTATATAT 1681 GTGTTTACATGCTCACACAGAAAACATCCTGAGTGACGTACAGGACATACGTTGGCAAAAGTCTGTGTAAATGTCTCATA 1761 AAATTAGATTTATGTTCATTGTGTTTTGGGATGTATAGCATGTAAATTATTTCATGTATTATTTAAAGGCAATTAAATGT 1841 TCATGCTTTAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | CD4+ T cell |
Location of target site | 3'UTR |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
Luciferase reporter assays confirmed MTMR6 as a direct miR-190b target.
... - Mohan M; Chandra LC; Torben W; Aye PP; et al., 2014, Journal of immunology (Baltimore, Md. : 1950). |
Article |
- Mohan M; Chandra LC; Torben W; Aye PP; et al. - Journal of immunology (Baltimore, Md. : 1950), 2014
HIV replication and the cellular micro-RNA (miRNA) machinery interconnect at several posttranscriptional levels. To understand their regulatory role in the intestine, a major site of HIV/SIV replication, dissemination, and CD4(+) T cell depletion, we profiled miRNA expression in colon following SIV infection (10 acute SIV, 5 uninfected). Nine (four up and five down) miRNAs showed statistically significant differential expression. Most notably, miR-190b expression showed high statistical significance (adjusted p = 0.0032), the greatest fold change, and was markedly elevated in colon and jejunum throughout SIV infection. In addition, miR-190b upregulation was detected before peak viral replication and the nadir of CD4(+) T cell depletion predominantly in lamina propria leukocytes. Interestingly non-SIV-infected macaques with diarrhea and colitis failed to upregulate miR-190b, suggesting that its upregulation was neither inflammation nor immune-activation driven. SIV infection of in vitro-cultured CD4(+) T cells and primary intestinal macrophages conclusively identified miR-190b upregulation to be driven in response to viral replication. Further miR-190b expression levels in colon and jejunum positively correlated with tissue viral loads. In contrast, mRNA expression of myotubularin-related protein 6 (MTMR6), a negative regulator of CD4(+) T cell activation/proliferation, significantly decreased in SIV-infected macrophages. Luciferase reporter assays confirmed MTMR6 as a direct miR-190b target. To our knowledge, this is the first report, which describes dysregulated miRNA expression in the intestine, that identifies a potentially significant role for miR-190b in HIV/SIV pathogenesis. More importantly, miR-190b-mediated MTMR6 downregulation suggests an important mechanism that could keep infected cells in an activated state, thereby promoting viral replication. In the future, the mechanisms driving miR-190b upregulation including other cellular processes it regulates in SIV-infected cells need determination.
LinkOut: [PMID: 24981450]
|
60 hsa-miR-190b Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT054581 | IGF1 | insulin like growth factor 1 | 4 | 1 | ||||||||
MIRT066966 | ATXN7L3B | ataxin 7 like 3B | 2 | 2 | ||||||||
MIRT192449 | SPRED1 | sprouty related EVH1 domain containing 1 | 2 | 2 | ||||||||
MIRT250414 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT306294 | KLHL24 | kelch like family member 24 | 2 | 2 | ||||||||
MIRT355845 | SGMS2 | sphingomyelin synthase 2 | 2 | 4 | ||||||||
MIRT437770 | MTMR6 | myotubularin related protein 6 | 1 | 1 | ||||||||
MIRT437771 | MTMR6 | myotubularin related protein 6 | 1 | 1 | ||||||||
MIRT437772 | Mtmr6 | myotubularin related protein 6 | 1 | 1 | ||||||||
MIRT444672 | CDKL2 | cyclin dependent kinase like 2 | 2 | 2 | ||||||||
MIRT446389 | PCDHB11 | protocadherin beta 11 | 2 | 2 | ||||||||
MIRT446634 | SDC3 | syndecan 3 | 2 | 2 | ||||||||
MIRT449410 | TRIM5 | tripartite motif containing 5 | 2 | 2 | ||||||||
MIRT449560 | GPC5 | glypican 5 | 2 | 2 | ||||||||
MIRT469928 | PTPRJ | protein tyrosine phosphatase, receptor type J | 2 | 6 | ||||||||
MIRT473736 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | 2 | 2 | ||||||||
MIRT474210 | LDHA | lactate dehydrogenase A | 2 | 2 | ||||||||
MIRT474583 | KLF6 | Kruppel like factor 6 | 2 | 2 | ||||||||
MIRT476732 | FOXN2 | forkhead box N2 | 2 | 2 | ||||||||
MIRT478455 | DAB2 | DAB2, clathrin adaptor protein | 2 | 2 | ||||||||
MIRT495327 | ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif 8 | 2 | 4 | ||||||||
MIRT498615 | MTRNR2L10 | MT-RNR2-like 10 | 2 | 12 | ||||||||
MIRT501734 | OVOL1 | ovo like transcriptional repressor 1 | 2 | 2 | ||||||||
MIRT501849 | MTRNR2L8 | MT-RNR2-like 8 | 2 | 14 | ||||||||
MIRT504678 | CYGB | cytoglobin | 2 | 4 | ||||||||
MIRT506517 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 2 | 6 | ||||||||
MIRT507984 | BCL2L13 | BCL2 like 13 | 2 | 4 | ||||||||
MIRT508444 | ZNF608 | zinc finger protein 608 | 2 | 4 | ||||||||
MIRT511366 | IL6ST | interleukin 6 signal transducer | 2 | 4 | ||||||||
MIRT520515 | TRA2B | transformer 2 beta homolog | 2 | 2 | ||||||||
MIRT524571 | CALML4 | calmodulin like 4 | 2 | 4 | ||||||||
MIRT531896 | INVS | inversin | 2 | 4 | ||||||||
MIRT533916 | TATDN2 | TatD DNase domain containing 2 | 2 | 2 | ||||||||
MIRT537503 | FAM13B | family with sequence similarity 13 member B | 2 | 2 | ||||||||
MIRT541689 | CCDC160 | coiled-coil domain containing 160 | 2 | 8 | ||||||||
MIRT544419 | ZNF460 | zinc finger protein 460 | 2 | 4 | ||||||||
MIRT544615 | CSDE1 | cold shock domain containing E1 | 2 | 2 | ||||||||
MIRT545076 | IL7R | interleukin 7 receptor | 2 | 2 | ||||||||
MIRT545849 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT547436 | MED4 | mediator complex subunit 4 | 2 | 2 | ||||||||
MIRT550157 | ZNF223 | zinc finger protein 223 | 2 | 4 | ||||||||
MIRT553948 | STAMBP | STAM binding protein | 2 | 2 | ||||||||
MIRT554395 | SERP1 | stress associated endoplasmic reticulum protein 1 | 2 | 2 | ||||||||
MIRT555667 | PGAM4 | phosphoglycerate mutase family member 4 | 2 | 4 | ||||||||
MIRT564193 | PM20D2 | peptidase M20 domain containing 2 | 2 | 2 | ||||||||
MIRT566792 | MKL2 | MKL1/myocardin like 2 | 2 | 2 | ||||||||
MIRT566843 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT572516 | KIAA0232 | KIAA0232 | 2 | 2 | ||||||||
MIRT607428 | NOTCH2NL | notch 2 N-terminal like | 2 | 10 | ||||||||
MIRT627779 | RAB30 | RAB30, member RAS oncogene family | 2 | 2 | ||||||||
MIRT635159 | ENO4 | enolase family member 4 | 2 | 2 | ||||||||
MIRT642159 | ADCYAP1R1 | ADCYAP receptor type I | 3 | 2 | ||||||||
MIRT646205 | DUSP10 | dual specificity phosphatase 10 | 2 | 2 | ||||||||
MIRT657007 | KCNMB4 | potassium calcium-activated channel subfamily M regulatory beta subunit 4 | 2 | 2 | ||||||||
MIRT665817 | TMEM161B | transmembrane protein 161B | 2 | 2 | ||||||||
MIRT667488 | MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 2 | 2 | ||||||||
MIRT707098 | ZNF850 | zinc finger protein 850 | 2 | 2 | ||||||||
MIRT708719 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT735521 | HUS1 | HUS1 checkpoint clamp component | 3 | 0 | ||||||||
MIRT736644 | AGPAT3 | 1-acylglycerol-3-phosphate O-acyltransferase 3 | 2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|